Genetic information to guide your psychiatric prescription decisions

Using pharmacogenomic testing to personalize antidepressants, anxiolytics, and more

Prescribing psychiatric medications is a complex process that often takes trial and error to find the right medication for each patient. By using pharmacogenomic (PGx) testing, psychiatry providers are uncovering genetic insights about their patients that may help them more quickly identify which medications to avoid and which to try first.

OneOme’s RightMed® test, plus the supporting PSYCHIATRY REPORT and MTHFR REPORT, are helping psychiatry providers identify effective treatments faster, leading to fewer side effects and less trial and error to find the right medication.

View our medication list >

Get a Sample RightMed psychiatry report

The Sample RightMed psychiatry report includes:

  • A personalized medication summary highlighting the medications most relevant to the patient
  • The psychiatric medications covered by the RightMed test, sorted by type of medication
  • Sample test results showing how medications are classified based on the severity of the predicted gene-drug interaction

Get started today to take control of your health.


The RightMed test: Giving you tools to guide your prescription decisions

The RightMed test gives providers insight into how a patient is predicted to respond to antidepressants, antipsychotics, anxiolytics, ADHD medications, and more. Using information from the RightMed test, psychiatry providers may identify the best place to start with their patients’ medications, cutting down on the time it takes to find an effective treatment.

When you order the RightMed test, you get:

comprehensive-test icon

A comprehensive PGx test that analyzes 27 genes and provides results for 300+ medications

MTHFR_sample_report icon

The option to add the MTHFR report as a complimentary add-on

psych report icon

A streamlined PSYCHIATRY REPORT, which features only medications relevant to psychiatry

rma icon

Access to the RightMed Advisor, an interactive tool that helps make results actionable

consult icon

Complimentary consults with OneOme’s clinical pharmacists

Learn more

When to use the RightMed test in psychiatry

Traditionally, psychiatry providers have thought to use PGx testing only after treatment has failed for a patient. This is shifting as psychiatry providers recognize the benefit to using PGx results earlier in treatment.

Here are just a few examples of how the RightMed test is being used in psychiatry:

OneOme circle icon

Prior to initiating first antidepressant, tricyclic antidepressant, or an adjunvant psychiatric medication being used for treatment of a mood disorder or substance abuse disorder

OneOme circle icon

After diagnosis of a comorbid psychiatric disorder and opioid use disorder or a comorbid psychiatric disorder and metabolic disorder

OneOme circle icon

After first antidepressant medication therapy failure in patients with major depressive disorder

OneOme circle icon

When patient experiences QTc prolongation effects after being prescribed escitalopram or citalopram

OneOme circle icon

If the patient is taking more than five medications

Download our Guide to the RightMed test for psychiatry for more information about using the test in psychiatry.

RightMed Patient Stories


“Carly is 17 years old, and for 10 years we struggled to control her anxiety, ADHD, and depression until we found the RightMed test,” Carly’s mom, Sandy, says. “I’m forever grateful and thrilled to know OneOme exists.”



“I believe this test has saved my daughter’s life because she now has a medication that is effective for her.” said Emma’s mother, Susan


Ready to get started?

Psych icon

Psychiatry report

View a sample of the RightMed psychiatry report.

Get report
form icon


Complete a simple test requisition form to place your first order.

Download Form
provider icon


Get more information, plus the tools you need to get started.

Download Kit
Limitations of the RightMed test
The RightMed tests cover many genes and hundreds of medications with clinical evidence supporting the gene-drug interaction. The RightMed test does not cover all psychiatric conditions or medications.